North American Traditional Women’s Herb – Standardized Black Cohosh (Actaea racemosa) Extract with 2.5%-8% Triterpene Glycosides

Product Description

Black Cohosh Extract contains triterpene glycosides and isoferulic acid as its core active components. It is derived from the dried rhizome of North American black cohosh (Actaea racemosa (L.) Nutt., formerly classified as Cimicifuga racemosa), and obtained through water-ethanol extraction and standardized purification to produce a stable triterpene glycoside-concentrated powder, with triterpene glycosides content ranging from 2.5% to 8%. As a traditional North American women’s herb, it has research support for menopause relief and emotional balance and is widely used in women’s health supplements and personal care formulations. This product selects authentic North American raw materials, standardizes the triterpene glycoside content, contains no hormone components, and is suitable for women’s health product development.

Black Cohosh Extract is one of the important plant ingredients in the global women’s health product market, with North America and Europe being the main consumer markets.

Why Choose Nutralighting

• Our Black Cohosh Extract is manufactured under strict ISO-compliant conditions.
• Every Black Cohosh Extract batch undergoes comprehensive testing for identity, potency, heavy metals, pesticide residues, microbial limits, and aflatoxins to ensure consistency and safety.
• Custom packaging available upon request

Basic Information

Standard Specifications (COA)

The following specifications are general reference values and are subject to the COA report of each batch.

Plant Material Introduction

The raw material of Black cohosh Extract product is the dried root and rhizome of Actaea racemosa (L.) Nutt. (formerly classified as Cimicifuga racemosa) of the Ranunculaceae family. It is mainly produced in the eastern United States and the Appalachian Mountain region. It is recorded in the “Commission E” Monograph of Germany and the European Pharmacopoeia.

Black cohosh has been used in North American traditional medicine for over 200 years, mainly for managing female menopause symptoms and menstrual regulation. Its main active components are triterpene saponins and isoferulic acid.

Core Efficacy

Black cohosh (Actaea racemosa) extract has a relatively strong research foundation in the area of menopausal symptom relief. Its core active components are triterpene glycosides (such as 26-deoxyactein) and isoferulic acid. Multiple randomized controlled studies have shown that standardized black cohosh extract has supportive effects in alleviating menopausal discomfort in postmenopausal women (such as hot flashes and mood swings) (Menopause, 2002). Mechanistic studies suggest it is related to selective modulation of estrogen receptor β (ERβ) and GABAergic neuron activity. Research indicates it has no proliferative effects on the endometrium and breast tissue and is supported by multiple safety studies for women’s health.

Regulatory and Regional Access Status

The following information is compiled based on publicly available regulatory data. Actual market access should be subject to the latest regulations of the target country.

Application Directions and Recommended Dosage

Recommended daily dosage reference

• General health purposes: use according to product specifications and formulators’ recommendations
• Personal care and skincare: the amount added in formulations depends on the specific product, recommended 0.1~2.0%

Appendix: References

(The following references are for technical reference. Some are open access and can be found on PubMed/PMC or journal websites)

[1] Blumenthal M. et al., The Commission E Monographs, 1998

[2] Hammersten J. et al., Phytotherapy Research, 2008: Randomized controlled trial of black cohosh extract for the treatment of menopausal symptoms

[3] Ernst E., Menopause, 2002: Systematic review of black cohosh for the treatment of menopausal symptoms

[4] EMA HMPC, Cimicifugae rhizoma, 2013

[5] Schmidt D, et al. (2002). Efficacy and safety of actaea racemosa in menopausal women with arthralgia. Menopause, 9(4), 280-289.

[6] Maffei-Hace D, et al. (2009). Mechanism of action of Cimicifuga racemosa on GABA receptors. Journal of Pharmacological and Experimental Therapeutics, 329(2), 656-664.

[7] Burdette JE, et al. (2001). Black cohosh (Cimicifuga racemosa): pharmacological activities. Journal of Alternative and Complementary Medicine, 7(6), 633-648.